UH Seidman Cancer Center Faculty Publications in Cell Therapy

May 2018

 

Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.<https://www.ncbi.nlm.nih.gov/pubmed/29342200>
Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, de Lima M, Wald DN.
PLoS One. 2018 Jan 17;13(1):e0191358. doi: 10.1371/journal.pone.0191358. eCollection 2018. Erratum in: PLoS One. 2018 May 2;13(5):e0197008<https://www.ncbi.nlm.nih.gov/pubmed/29718995>.

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.<https://www.ncbi.nlm.nih.gov/pubmed/29330398>
Kebriaei P, Cutler C, de Lima M, Giralt S, Lee SJ, Marks D, Merchant A, Stock W, van Besien K, Stelljes M.
Bone Marrow Transplant. 2018 Apr;53(4):449-456. doi: 10.1038/s41409-017-0019-y. Epub 2018 Jan 12. No abstract available.

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.<https://www.ncbi.nlm.nih.gov/pubmed/29325829>
Tamari R, Oran B, Hilden P, Maloy M, Kongtim P, Papadopoulos EB, Rondon G, Jakubowski AA, Andersson BS, Devlin SM, Ahmed S, Popat UR, Ponce D, Chen J, Sauter C, Young JW, de Lima M, Perales MA, O'Reilly RJ, Giralt SA, Champlin RE, Castro-Malaspina H.
Biol Blood Marrow Transplant. 2018 Jan 8. pii: S1083-8791(18)30001-6. doi: 10.1016/j.bbmt.2018.01.001. [Epub ahead of print]

Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle.<https://www.ncbi.nlm.nih.gov/pubmed/29322027>
Malek E, El-Jurdi N, Kröger N, de Lima M.
Front Oncol. 2017 Dec 11;7:287. doi: 10.3389/fonc.2017.00287. eCollection 2017. Review.

Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.<https://www.ncbi.nlm.nih.gov/pubmed/29295650>
Malek E, Gupta V, Creger R, Caimi P, Vatsayan A, Covut F, Bashir Q, Champlin R, Delgado R, Rondon G, Cooper B, , Lazarus HM, Qazilbash M.
Leuk Lymphoma. 2018 Jan 2:1-8. doi: 10.1080/10428194.2017.1408086. [Epub ahead of print]

Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes.<https://www.ncbi.nlm.nih.gov/pubmed/29277360>
Brammer JE, Chihara D, Poon LM, Caimi P, de Lima M, Ledesma C, Rondon G, Ciurea SO, Nieto Y, Fanale M, Dabaja B, Maziarz RT, Champlin RE, Hosing C, Oki Y.
Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e41-e50. doi: 10.1016/j.clml.2017.10.001. Epub 2017 Oct 12.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.<https://www.ncbi.nlm.nih.gov/pubmed/29275139>
Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Peter Gale R, Lazarus HM, Ustun C, Copelan E, Ky Hamilton B, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, Khoury HJ, Weisdorf DJ.
Biol Blood Marrow Transplant. 2017 Dec 21. pii: S1083-8791(17)31710-X. doi: 10.1016/j.bbmt.2017.12.784. [Epub ahead of print]

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study.<https://www.ncbi.nlm.nih.gov/pubmed/29225164>
Kharfan-Dabaja MA, Raj R, Nikolaenko L, Ahmed S, Reddy N, Nathan S, Cherry M, El-Jurdi N, Obiozor C, Fenske TS, Song J, Muzzafar T, Ayala E, Savani B, Khawandanah M, Caimi PF, Hamadani M, Forman SJ, Hussaini M, de Lima M, Olteanu H, Shah B, Chavez JC, Al Malki M, Kumar A, Ganguly S.
Biol Blood Marrow Transplant. 2018 Mar;24(3):486-493. doi: 10.1016/j.bbmt.2017.11.033. Epub 2017 Dec 7.

Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.<https://www.ncbi.nlm.nih.gov/pubmed/29199482>
Tandra A, Covut F, Cooper B, Creger R, Brister L, McQuigg B, Caimi P, Malek E, Tomlinson B, Lazarus HM, Otegbeye F, Kolk M, de Lima M, Metheny L.
Leuk Lymphoma. 2017 Dec 4:1-8. doi: 10.1080/10428194.2017.1390234. [Epub ahead of print]

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.<https://www.ncbi.nlm.nih.gov/pubmed/29197676>
Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI; Acute Leukemia Committee of the CIBMTR.
Biol Blood Marrow Transplant. 2018 Apr;24(4):726-733. doi: 10.1016/j.bbmt.2017.11.025. Epub 2017 Dec 25.

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.<https://www.ncbi.nlm.nih.gov/pubmed/29155319>
William BM, Wang T, Haagenson MD, Fleischhauer K, Verneris M, Hsu KC, de Lima MJ, Fernandez-Viña M, Spellman SR, Lee SJ, Hill BT.
Biol Blood Marrow Transplant. 2018 Apr;24(4):827-831. doi: 10.1016/j.bbmt.2017.11.003. Epub 2017 Nov 16.

Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.<https://www.ncbi.nlm.nih.gov/pubmed/29108368>
Caimi PF, Cooper BW, William BM, Dowlati A, Barr PM, Fu P, Pink J, Xu Y, Lazarus HM, de Lima M, Gerson SL.
Oncotarget. 2017 Aug 9;8(45):79864-79875. doi: 10.18632/oncotarget.20094. eCollection 2017 Oct 3.

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.<https://www.ncbi.nlm.nih.gov/pubmed/29703778>
LaCasce AS, Bociek RG, Sawas A, Caimi P, Agura E, Matous J, Ansell SM, Crosswell HE, Islas-Ohlmayer M, Behler C, Cheung E, Forero-Torres A, Vose J, O'Connor OA, Josephson N, Wang Y, Advani R.
Blood. 2018 Apr 27. pii: blood-2017-11-815183. doi: 10.1182/blood-2017-11-815183. [Epub ahead of print]

A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib.<https://www.ncbi.nlm.nih.gov/pubmed/28794071>
Winter AM, Landsburg DJ, Mato AR, Isaac K, Hernandez-Ilizaliturri FJ, Reddy N, Smith S, Shadman M, Smith MR, Caimi P, Jagadeesh D, Hill BT.
Blood. 2017 Aug 9. pii: blood-2017-05-786988. doi: 10.1182/blood-2017-05-786988.

Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model.<https://www.ncbi.nlm.nih.gov/pubmed/29520362>
Metheny L, Eid S, Lingas K, Ofir R, Pinzur L, Meyerson H, Lazarus HM, Huang AY.
Front Med (Lausanne). 2018 Feb 22;5:37. doi: 10.3389/fmed.2018.00037. eCollection 2018.

Share
Facebook
Twitter
Pinterest
Email
Print